SEC-sourced researchBeta
USNA
USANA HEALTH SCIENCES INC
Company comparison ↗
Data passport
- CIK
- 0000896264
- Exchange
- NYSE
- Business activity
- — · SIC 2833
- Financial inputs
- 6/6
- Filing date
- Oct 5, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 921,010,000.0000 | Mar 16, 2026 |
| December 2024 | 854,503,000.0000 | Mar 16, 2026 |
| December 2025 | 925,257,000.0000 | Mar 16, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 925,257,000.0000 | 10,760,000.0000 | 22,349,000.0000 | 742,915,000.0000 | 156,643,000.0000 | Mar 16, 2026 |
| December 2024 | 854,503,000.0000 | 42,030,000.0000 | 60,992,000.0000 | 748,193,000.0000 | 161,861,000.0000 | Mar 16, 2026 |
| December 2023 | 921,010,000.0000 | 63,788,000.0000 | 70,641,000.0000 | — | — | Mar 16, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $925.26M | December 2025 | Mar 16, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $854.5M | December 2024 | Mar 16, 2026 | 10-K |
| Net incomeNetIncomeLoss | $10.76M | December 2025 | Mar 16, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $22.35M | December 2025 | Mar 16, 2026 | 10-K |
| Total assetsAssets | $742.92M | December 2025 | Mar 16, 2026 | 10-K |
| Total liabilitiesLiabilities | $156.64M | December 2025 | Mar 16, 2026 | 10-K |